ADHD - combined type
Clinical trials for ADHD - combined type explained in plain language.
Never miss a new study
Get alerted when new ADHD - combined type trials appear
Sign up with your email to follow new studies for ADHD - combined type, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common ADHD drug tame attention issues in rare KBG syndrome?
Disease control Recruiting nowThis trial tests whether methylphenidate, a standard ADHD medication, can reduce attention and hyperactivity problems in children and adolescents with KBG syndrome, a rare genetic condition often accompanied by ADHD-like symptoms. Participants receive alternating blocks of the dr…
Matched conditions: ADHD - COMBINED TYPE
Phase 4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
A common antidepressant may tame anxiety in kids with autism and ADHD — a trial puts it to the test
Symptom relief Recruiting nowThis trial tests whether sertraline, a widely used antidepressant, can reduce anxiety in children and teens aged 8 to 17 with neurodevelopmental disorders such as autism, ADHD, Fragile X syndrome, and Tourette syndrome. Participants receive either sertraline or a placebo for seve…
Matched conditions: ADHD - COMBINED TYPE
Phase 2 • Sponsor: Holland Bloorview Kids Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a brain scan predict ADHD drug response?
Knowledge-focused Recruiting nowThis study uses brain imaging (fMRI and MRS) to see how a single dose of methylphenidate changes brain activity and glutamate levels in 30 adults with ADHD. Participants will receive both the drug and a placebo in a double-blind crossover design. The goal is to find brain-based m…
Matched conditions: ADHD - COMBINED TYPE
Phase 4 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC